Ac21 - Timothy Yap: Dna Damage Repair

AC21 - Timothy Yap: DNA Damage Repair

Cholangiocarcinoma Foundation

Developing novel therapeutic strategies to target DNA damage response

TRESR trial: Investigating an ATRi in patients with DNA damage repair loss-of-function mutant tumors

MS1 Targeting DNA damage response and HRD in breast cancer Timothy A. Yap

San Antonio Breast Cancer Symposium

Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours

DNA damage response inhibitors in breast cancer

Use of PARP1-selective and ATR inhibitors to target DDR signalling pathway

Dr Timothy Yap Reiterates the Unmet Medical Need for Molecularly Targeted Agents in Solid Tumors

Phase I research on DNA damage repair at the 2024 ASCO annual meeting

MD Anderson Cancer Center

DNA damage repair pathways and WEE1 as possible therapeutic targets in SCLC

Investigating the ATR inhibitor elimusertib in advanced solid tumors

Immunofluroescence Imaging of DNA damage and repair in Cancer Cells | Protocol Preview

JoVE (Journal of Visualized Experiments)

Ross Chapman: Repairing DNA damage

Nuffield Department of Medicine

NCRI 2010: Cancer therapies that target DNA damage repair

VT3989 is safe and well tolerated in patients with advanced malignant mesothelioma and NF2m cancers

Targeting the DNA damage response

Dr. Oh on the Importance of Identifying DNA Damage Repair Mutations in Prostate Cancer

DNA Repair Deficiency and Immunotherapy Response

Exploiting DNA damage in colorectal cancer to improve patient survival

DNA damage repair mutations and poor chemotherapy response in bladder cancer